Clinically accessible eye-tracking in thyroid-associated ophthalmopathy: exploratory classification modeling and gaze allocation to disease-related periocular images. [PDF]
Yang C +5 more
europepmc +1 more source
Quantitative MRI Assessment of Orbital Structures in Radioactive Iodine-131 Therapy for Inactive Graves' Ophthalmopathy. [PDF]
Wang M, Shen ZY, Wu XW.
europepmc +1 more source
Epigenetic Modulation of Thyroid-Stimulating Hormone Receptor Expression in Orbital Fibroblasts From Graves' Ophthalmopathy: Target for Treatment. [PDF]
Chompoowong R +9 more
europepmc +1 more source
HTLV-1-associated uveitis mimicking thyroid-associated ophthalmopathy during antithyroid therapy: a diagnostic pitfall and management challenge. [PDF]
Kasamatsu D +4 more
europepmc +1 more source
Multifocal visual evoked potential in thyroid associated ophthalmopathy. [PDF]
Salah MI +5 more
europepmc +1 more source
Efficacy and safety of tocilizumab in the treatment of Graves' orbitopathy: a systematic review and meta-analysis. [PDF]
Chen J, Chen Y, Huang H, Duan H.
europepmc +1 more source
Triglyceride-driven pathogenesis in thyroid-associated ophthalmopathy: a dual approach of clinical correlation and genetic causality. [PDF]
Cao JM, Chen HY, Zhang F, Xiong W.
europepmc +1 more source
Selective extraocular muscle regression following tocilizumab in active thyroid associated ophthalmopathy: a 3D MRI-based retrospective study. [PDF]
Nan F +14 more
europepmc +1 more source
Correction: Extraocular muscle index as a novel indicator of inflammatory condition in graves' ophthalmopathy patients. [PDF]
Wu F +5 more
europepmc +1 more source
Gypenosides attenuate H<sub>2</sub>O<sub>2</sub>-induced oxidative stress in orbital fibroblasts from thyroid-associated ophthalmopathy by activating the Nrf2/ERK/HO-1 signaling pathway. [PDF]
Ma C +6 more
europepmc +1 more source

